Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines

Acta Pharmacologica Sinica

Volumn 25, Issue 2, 2004, Pages 129-136

  Guo, Lian Qing ^a   Yamazoe, Yasushi ^b  

^a JINLING HOSPITAL   (China)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Cytochrome P 450 enzyme system; Drug interaction; Enzyme inhibitors; Grapefruit juice; Herbal medicine; Psoralens

Indexed keywords

6',7' DIHYDROXYBERGAMOTTIN; BERGAMOTTIN; BERGAMOTTIN 6',7' EPOXIDE; CYTOCHROME P450; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DIAZEPAM; DIMER; ENZYME INHIBITOR; FUROCOUMARIN DERIVATIVE; HERBACEOUS AGENT; MONOMER; NIFEDIPINE; OMEPRAZOLE; PARADISIN A; PARADISIN B; PARADISIN C; PSORALEN DERIVATIVE; TOLBUTAMIDE; UNCLASSIFIED DRUG;

CITRUS FRUIT; COMPETITIVE INHIBITION; ENZYME INHIBITION; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; NONHUMAN; RAT; REVIEW; TRADITIONAL MEDICINE;

ANIMALS; BEVERAGES; CITRUS; CYTOCHROME P-450 ENZYME SYSTEM; DRUGS, CHINESE HERBAL; HUMANS; MICROSOMES, LIVER; PLANTS, MEDICINAL; PSORALENS;

EID: 0442278008     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Pathak MA, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B Biol 1992; 14: 3-22.
2. Namba T, auther; Zhong GY, translater. The encyclopedia of Wakan-Yaku (traditional Sino-Japanese medicines) with color pictures. (a Chinese version with English indexes) 1st ed. Beijing: China Medical & Pharmaceutical Science and Technology Publishing House. 2001.
3. Kleiner HE, Vulimiri SV, Reed MJ, Uberecken A, DiGiovanni J. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem Res Toxicol 2002; 15: 226-35.
4. Tantcheva-Poor I, Servera-Llaneras M, Scharffetter-Kochanek K, Fuhr U. Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients. Br J Dermatol 2001; 144: 1127-32.
5. Maenpaa J, Sigusch H, Raunio H, Syngelma T, Vuorela P, Vuorela H, et al. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol 1993; 45: 1035-42.
6. Kharasch ED, Hankins DC, Taraday JK. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity. Drug Metab Dispos 2000; 28: 28-33.
7. Koenigs LL, Trager WF. Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins. Biochemistry 1998; 37: 13184-93.
8. Harrison TL, Zangerl AR, Schuler MA, Berenbaum MR. Developmental variation in cytochrome P450 expression in Papilio polyxenes in response to xanthotoxin, a hostplant allelochemical. Arch Insect Biochem Physiol 2001; 48: 179-89.
9. Hung CF, Berenbaum MR, Schuler MA. Isolation and characterization of CYP6B4, a furanocoumarin-inducible cytochrome P450 from a polyphagous caterpillar (Lepidoptera: papilionidae). Insect Biochem Mol Biol 1997; 27: 377-85.
10. Scott JG. Inhibitors of CYP6D1 in house fly microsomes. Insect Biochem Mol Biol 1996; 26: 645-9.
11. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc 2000; 75: 933-42.
12. Edwards DJ, Bellevue FH 3rd, Woster PM. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996; 24: 1287-90.
13. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M, Yamazoe Y. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997; 7: 391-6.
14. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 1997; 25: 1228-33.
15. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 1998; 11: 252-9.
16. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997; 99: 2545-53.
17. Guengerich FP, Kim DH. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 1990; 11: 2275-9.
18. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993; 54: 589-94.
19. Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sci 1996; 59: 1025-30.
20. Fukuda K, Ohta T, Yamazoe Y. Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction. Biol Pharm Bull 1997; 20: 560-4.
21. Ohta T, Maruyama T, Nagahashi M, Miyamoto Y, Hosoi S, Kiuchi F, et al. Paradisin C: a new CYP3A4 inhititor from grapefruit juice. Tetrahedron 2002; 58: 6631-5.
22. Tassaneeyakul W, Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys 2000; 378: 356-63.
23. Wang RW, Newton DJ, Liu N, Atkins WM, Lu AYH. Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent. Drug Metab Dispos 2000; 28: 360-6.
24. Tassaneeyakul Wi, Tassaneeyakul Wo, Vannaprasaht S, Yamazoe Y. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Br J Clin Pharmacol 2000; 49: 139-44.
25. Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci 2002; 71: 1149-60.
26. Bendriss EK, Bechtel Y, Bendriss A, Humbert Ph, Paintaud G, Magnette J, et al. Inhibition of caffeine metabolism by 5-methoxypsoralen in patients with psoriasis. Br J Clin Pharmacol 1996; 41: 421-4.
27. Fukuda K, Guo LQ, Ohashi N, Yoshikawa M, Yamazoe Y. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B 2000; 741: 195-203.
28. Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos 2000; 28: 766-71.
29. Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit juice-felodipine interaction: effect of naringin and 6′,7′ -dihydroxybergamottin in humans. Clin Pharmacol Ther 1998; 64: 248-56.
30. Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 2000; 68: 468-77.
31. Nicolosi E, Deng ZN, Gentile A, La Malfa S, Continella G, Tribulato E. Citrus phylogeny and genetic origin of important species as investigated by molecular markers. Theor Appl Genet 2000; 100: 1155-66.
32. Morton J. Grapefruit. In: Morton JF, editor. Fruits of Warm Climates. Miami: The editor; 1987. p152-8.
33. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, et al. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999; 65: 237-44.
34. Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001; 69: 14-23.
35. Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ. Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm Res 1999; 16: 478-85.
36. Guo LQ, Taniguchi M, Xiao YQ, Baba K, Ohta T, Yamazoe Y. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol 2000; 82: 122-9.
37. Guo LQ, Taniguchi M, Chen QY, Baba K, Yamazoe Y. Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous or citrus crude drugs and their relative prescriptions. Jpn J Pharmacol 2001; 85: 399-408.
38. Ishihara K, Kushida H, Yuzurihara M, Wakui Y, Yanagisawa T, Kamei H, et al. Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica. J Pharm Pharmacol 2000; 52: 1023-9.
39. Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol 2000; 56: 411-5.
40. Mohri K, Uesawa Y, Sagawa K. Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: Induction of rat hepatic P-450 by grapefruit juice. Drug Metab Dispos 2000; 28: 482-6.